Yellow fever is an acute viral hemorrhagic disease caused by a flavivirus. The causative agent belongs to the genus Flavivirus and is transmitted to humans primarily through the bites of infected mosquitoes, specifically the Aedes and Haemagogus species. In the urban setting, transmission occurs between humans and mosquitoes, whereas in tropical rainforests, monkeys serve as the primary reservoir while forest mosquitoes transmit the virus from non-human primates to humans. A sylvatic cycle operates in the jungle, an urban cycle involves human-to-human transmission via Aedes aegypti, and an intermediate cycle occurs in humid savannas of Africa where semi-domestic mosquitoes infect both monkeys and humans.
Following the mosquito bite, the virus replicates in regional lymph nodes and spreads via the bloodstream to the liver, spleen, kidneys, and bone marrow. The disease typically progresses through three distinct clinical phases:
Most infected individuals experience mild illness or remain asymptomatic. For those who develop symptoms, the incubation period lasts three to six days. Classic signs include high-grade fever, severe back pain, generalized body weakness, and flushing of the face. In severe cases, the clinical picture worsens drastically. Patients develop pronounced jaundice, giving the skin and sclera a yellow tint, which explains the name of the disease. Black vomitus (hematemesis) occurs due to gastrointestinal bleeding, alongside bleeding from the gums and nose. Oliguria or anuria signals impending renal failure, carrying a high mortality rate if left unmanaged.
Comprehensive nursing assessment involves monitoring vital signs closely, tracking strict fluid intake and output, and inspecting the skin and mucous membranes for petechiae, purpura, or active bleeding. Nurses must watch for signs of worsening liver and kidney function. Laboratory confirmation relies on serological tests such as ELISA or PCR to detect viral RNA or antibodies. A detailed travel and vaccination history is vital during initial patient intake to differentiate yellow fever from other endemic conditions like malaria or Lassa fever.
There is no specific antiviral cure for yellow fever; medical management is entirely supportive. Treatment focuses on stabilizing vital signs, managing shock, correcting electrolyte imbalances, and providing blood transfusions if severe hemorrhage occurs. Analgesics and antipyretics are administered for pain and fever, but medications like aspirin or ibuprofen must be avoided due to the risk of exacerbating bleeding tendencies. Patients with acute kidney injury may require temporary dialysis. Isolation of the patient from mosquito bites is also enforced to prevent further local transmission within the health facility.
Vaccination remains the single most important measure for preventing yellow fever. The 17D live-attenuated vaccine provides lifelong immunity for most people after a single dose and is administered subcutaneously. Primary health care clinics ensure routine immunization for infants and travelers to endemic zones. Additional preventive measures include vector control strategies such as clearing stagnant water around homes, using insecticide-treated mosquito nets, and wearing protective clothing to minimize mosquito bites.
Public health surveillance is critical for early detection and containment of yellow fever outbreaks. Nurses play a frontline role in reporting suspected cases promptly to health authorities to initiate vaccination campaigns and vector control. Community health education empowers local populations to recognize early symptoms, seek prompt medical attention instead of relying on unverified herbal remedies, and participate in mass immunization exercises. Engaging community leaders helps overcome vaccine hesitancy and improves coverage during outbreak responses.